A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)

Recruiting now

Conditions studied: Food Allergies, Peanut Allergies, Egg Allergy, Milk Allergy

In brief

The goal of this observational study is to learn about the long-term outcomes of children and young people who underwent an 18-month course of oral immunotherapy (OIT) treatment for peanut, egg or milk allergy. It aims to: • Compare long-term changes in health-related quality of life (HRQL) at 5-15 years after stopping OIT in participants who achieved remission and those who did not. Participants will attend a single follow-up visit for: * A blood test * Skin prick test (SPT) * Allergy questionnaires

Key facts

Study ID

NCT07359183

Run by

Murdoch Childrens Research Institute

People needed

147

Starts

2026-01-13

Expected to finish

2027-01-01

Last updated by the study team

2026-02-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous participant of PEAT, PrEMO, PPOIT-001 or PPOIT-002 parent study
• Received at least one dose of OIT treatment in the parent study
• Written informed consent from participant and/or parent/guardian (if below 18 years of age)

You may not qualify if…

• Have any conditions that, in the opinion of the investigator, precludes participation for reason of safety

Where it is running

• Murdoch Children's Research Institute — Parkville, Victoria, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.